AMYLIN PHARMACEUTICALS INC Capital Expenditures
AMYLIN PHARMACEUTICALS INC reported Capital Expenditures of $21.50 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $11.15M, a 26.74% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $10.35M, a 3.36% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $13.15M, a 15.57% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $16.07M, a 21.16% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2011 was $54.45M, a 40.25% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2010 was $91.13M, a 40.06% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2009 was $152.05M, a 48.47% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2008 was $295.06M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2012-06-30 | $11.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $21.50M 10-Q · filed 2012-08-03 | $34.65M derived: sum of 3 quarters · filed 2012-08-03 | $50.72M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $10.35M 10-Q · filed 2012-05-07 | $23.50M derived: sum of 2 quarters · filed 2012-05-07 | $39.57M derived: sum of 3 quarters · filed 2012-05-07 | $54.79M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $29.22M derived: sum of 2 quarters · filed 2012-02-22 | $44.44M derived: sum of 3 quarters · filed 2012-08-03 | $54.45M 10-K · filed 2012-02-22 |
| 2011-09-30 | $16.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $31.29M derived: sum of 2 quarters · filed 2012-08-03 | $41.31M 10-Q · filed 2011-10-28 | $56.88M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $15.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $25.24M 10-Q · filed 2012-08-03 | $40.81M derived: sum of 3 quarters · filed 2012-08-03 | $61.19M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $10.01M 10-Q · filed 2012-05-07 | $25.59M derived: sum of 2 quarters · filed 2012-05-07 | $45.97M derived: sum of 3 quarters · filed 2012-05-07 | $73.61M derived: sum of 4 quarters · filed 2012-05-07 |
| 2010-12-31 | $15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $35.95M derived: sum of 2 quarters · filed 2012-02-22 | $63.60M derived: sum of 3 quarters · filed 2012-02-22 | $91.13M 10-K · filed 2012-02-22 |
| 2010-09-30 | $20.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $48.03M derived: sum of 2 quarters · filed 2011-10-28 | $75.56M 10-Q · filed 2011-10-28 | $108.49M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $27.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $55.18M 10-Q · filed 2011-08-08 | $88.11M derived: sum of 3 quarters · filed 2012-02-22 | $136.51M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $27.53M 10-Q · filed 2011-05-05 | $60.46M derived: sum of 2 quarters · filed 2012-02-22 | $108.86M derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | $32.93M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $81.33M derived: sum of 2 quarters · filed 2012-02-22 | $152.05M 10-K · filed 2012-02-22 | |
| 2009-09-30 | $48.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $119.12M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $70.72M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $295.06M 10-K · filed 2011-02-25 |